In fact, ROR1 has been established to have prognostic significance in several cancers, including breast cancer, colorectal cancer, chronic lymphocytic leukemia, ovarian cancer, lung cancer, and diffuse large B-cell lymphoma [17,29,30,31,32,33]. This evidence concerns the gene ROR1 and ovarian carcinoma.